{"database": "lobbying", "table": "lobbying_activities", "rows": [[3801742, "5ad581d1-e060-4fd9-b402-66991b7a5e37", "Q1", "ELITE STRATEGIC SERVICES", 401108852, "CONSERVATIVES FOR PROPERTY RIGHTS", 2026, "first_quarter", "TRD", "Special 301 Report - bolstering U.S. advocacy abroad for respecting intellectual property rights U.S. Trade Representative Request for Comments Regarding Foreign Nations Freeloading on American-Financed Innovation (Docket No. USTR-2025-0011) Employ robust trade policies and pressure tactics to cudgel foreign freeloaders to to stop using drug pricing disparities as a nontariff trade barrier and begin paying their fair share-actual market value-for U.S. medicines U.S. Trade Representative Request for Comments on the Operation of the Agreement between the United States of America, the United Mexican States, and Canada (Docket No. USTR-2025-0004) Urging pursuit in ongoing trade negotiations to ensure Japanese biopharma price controls do not thwart American medical innovation in global markets", "HOUSE OF REPRESENTATIVES,SENATE,U.S. Trade Representative (USTR)", 0, 0, "2026-04-01T15:25:31-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["3801742"], "units": {}, "query_ms": 0.3165560192428529, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}